Viz.ai vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Viz.ai applies AI to medical imaging to detect critical conditions and automatically coordinate care teams, reducing time from diagnosis to treatment for stroke and other emergencies.
About
Viz.ai is a healthcare AI company founded in 2016 that applies computer vision and AI to medical imaging to detect critical conditions and automate care coordination workflows. The platform analyzes CT scans and other medical images in real time, identifying conditions including large vessel occlusion stroke, pulmonary embolism, aortic dissection, and incidental findings, then automatically notifying and coordinating the relevant specialists through a HIPAA-compliant communication platform. Viz.ai has received FDA clearance for over 20 AI algorithms and is deployed at over 1,400 hospital sites across the United States. The company raised over $250M at a $1.2B valuation and has demonstrated that AI-powered care coordination reduces door-to-treatment time for stroke by tens of minutes, which translates directly into better patient outcomes. The platform creates a connected care team workflow where radiologists, neurologists, ER physicians, and interventionalists are automatically looped in when a critical finding is detected. Viz.ai serves as essential care coordination infrastructure for time-sensitive conditions where rapid multi-specialty response is critical to preventing death or disability.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.